Teva and Active extend collaboration for multiple sclerosis drug

02/8/2010 | MarketWatch

Teva Pharmaceutical Industries expanded a deal with Active Biotech for multiple sclerosis drug laquinimod to include distribution rights in the Nordic and Baltic regions. The companies are conducting global late-stage trials of the once-daily oral treatment in patients with relapsing-remitting multiple sclerosis.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX